The Weight Loss Pill That Launched a Thousand Dreams (and Some Disappointments) Novo Nordisk's rise to becoming Europe's most valuable company is a testament to the power of innovation in the pharmaceutical industry.
However, beneath the surface, cracks are beginning to show.
The Danish drugmaker's reliance on its weight loss franchise, particularly Ozempic and Wegovy, has raised concerns about its ability to sustain growth in an increasingly competitive market.